Mark Levick is the founder of Alvotech. Alvotech has raised $475M in total funding. Latest round: Growth. Backed by Arctica Finance, Arion Bank, Landsbankinn.
Mark Levick is the CEO of Alvotech, a biopharmaceutical company specializing in the development and manufacture of biosimilar medicines. He is focused on the company's mission to increase patient access to high-quality, cost-effective biosimilar medicines globally.
Full founder directory · Investor directory · Company funding database · Fundraising library